Covidien achieves CE Mark for Nellcor SpO2 patient monitoring system
27 November 2014
Covidien has announced EU approval for its Nellcor Bedside SpO2
patient monitoring system, PM100N.
The system features home care and sleep study modes that comply
with standards for medical electrical equipment used in the home
health care environment.
It features continuous monitoring of blood
oxygenation (SpO2) and pulse rate, along with patient trend data to
help clinicians detect and respond to dangerous respiratory events
sooner. With Covidien-exclusive digital signal processing, the
PM100N offers speed and accuracy, and reliable pulse oximetry
readings, even during low patient perfusion, motion and other forms
of signal interference.
The pulse oximetry system incorporates unique SatSeconds alarm
management technology to help distinguish between serious and minor
events, reducing clinically insignificant desaturation alarms. The
monitor can also be password-protected to prevent lay users from
inadvertently modifying settings.
“Just because a patient is discharged from the hospital does not
mean his or her care ends,” said Dr. Scott Kelley, chief medical
officer, Respiratory and Monitoring Solutions, Covidien. “The
continuation of safe, quality care for patients in all settings,
including the home, is something we are focused on at Covidien. This
new system includes all of the leading Nellcor technology that
clinicians have trusted for more than 30 years, with additional
features that make it well suited to the home healthcare